Van Hav'RX SRL
Van Hav'RX reported revenue of 0 € for the 2025 financial year (annual accounts filed with the NBB on 19 Jun 2026).
The score of Van Hav'RX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Van Hav'RX's annual accounts
| 2025 | |
|---|---|
| Revenue | 0 € |
| Net result | 280,662 € |
| Equity | 5,662 € |
| Cash | 56,303 € |
| EBITDA | 379,552 € |
| Total assets | 403,743 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 Jun 2026
Van Hav'RX's financial analysis
- Solvency1.4%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Van Hav'RX
Van Hav'RX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1021.273.705
- VAT number
- BE1021273705
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 20 Mar 2025
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 19 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Van Hav'RX (SRL) has been based in Liège since 2025, active in: medical specialists activities. For 2025, it reports revenue of 0 €, a net profit of 280,662 € and equity of 5,662 €. Its solvency stands at 1.4%, below the median of its sector (65.0%).
Companies similar to Van Hav'RX
Companies in the same business, of comparable size and area, outside its group.
- Palmen International Management Services Business and other management consultancy activities Brasschaat · balance sheet 403,932 €
- Lusyl Business and other management consultancy activities Deinze · balance sheet 403,435 €
- Fresma Rotselaar · balance sheet 403,647 €
- Cabinet Medical B.Michel Mons · balance sheet 403,903 €
- B&A Concept Liège · balance sheet 404,082 €
- Archimedic Molenbeek-Saint-Jean · balance sheet 403,348 €
Frequently asked questions about Van Hav'RX
What is the revenue of Van Hav'RX?
According to the 2025 annual accounts filed with the NBB, the revenue of Van Hav'RX amounts to 0 €.
What is the VAT number of Van Hav'RX?
In Belgium, the VAT number is the company number prefixed with BE: BE1021273705 for Van Hav'RX, if the company is VAT-registered. Its company number (CBE) is 1021.273.705.
Where is the registered office of Van Hav'RX?
According to the CBE register, the registered office of Van Hav'RX is in 4000 Liège.
What is the equity of Van Hav'RX?
At the close of the 2025 financial year, the equity of Van Hav'RX amounts to 5,662 €, a solvency of 1.4% of total assets.
Who manages Van Hav'RX?
The register lists 1 active mandates at Van Hav'RX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Van Hav'RX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →